Context Therapeutics Inc. — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2022-02-15

Reporting Person: Rencher William F. (Former Section 16 officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-15	Stock Option (right to buy)	$2.05	A	8000	Acquired	2032-02-14	Common Stock (8000.0)	Direct

Footnotes

F1: The stock option vests in equal installments with 1/10th vesting on the date of this grant and each grant thereafter occurring on the last day of each calendar month until fully vested on October 31, 2022.